Perle Bioscience is dedicated to finding novel treatments for type 1 diabetes with the ultimate goal of eliminating the disease all together. Perle has discovered novel human beta regeneration peptides for which it has filed "composition of matter" patents. Perle's total IP portfolio comprises 12 issued and pending patents all in the diabetes space. The company was founded by Dr. Claresa Levetan, MD and a Fellow with Distinction of the American College of Endocrinology. Dr. Levetan is a noted endocrinologist, has been internationally recognized as being on the forefront of diabetes research, and has been published in many medical journals. She received the Roche Diagnostics prestigious award for innovative diabetes research, and has been invited as a visiting scholar at Harvard University's Joslin Diabetes Center.
| Website | http://www.perlebioscience.com |
| Revenue | $4.8 million |
| Employees | View employees |
| Founded | 2013 |
| Address | 520 Folly Rd Ste P212, Charleston, South Carolina 29412, US |
| Phone | +1 843-568-2603 |
| Industry | Manufacturing General, Biotechnology, Manufacturing, Drug Discovery |
| Competitors | Roche, Thermo Fisher Scientific, Genentech, Illumina, MilliporeSigma, Bio-Rad Laboratories, QIAGEN, Verily, Applied Biosystems Inc., Aquabio Inc +41 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 54 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 541 Companies |
Looking for a particular Perle Bioscience Inc employee's phone or email?
Perle Bioscience Inc Questions
The Perle Bioscience Inc annual revenue was $4.8 million in 2026.
Perle Bioscience Inc is based in Charleston, South Carolina.
The NAICS codes for Perle Bioscience Inc are [32, 54, 325, 3254, 541].
The SIC codes for Perle Bioscience Inc are [28, 283].
